{
  "trial_id": "NCT00415610",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Baseline systolic blood pressure, Glasgow Coma Scale (GCS) score, Hematoma volume, Location of intracerebral hemorrhage, History of chronic hypertension, History of ischemic stroke, Serum creatinine level, Platelet count, Blood glucose level, History of congestive heart failure, History of myocardial infarction, Use of anticoagulants, Use of antihypertensive medications, Time from symptom onset to treatment initiation.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Initial SBP",
          "Baseline systolic blood pressure"
        ],
        [
          "Initial Hematoma Volume",
          "Hematoma volume"
        ],
        [
          "Baseline Measures - Timing of Treatment",
          "Time from symptom onset to treatment initiation"
        ],
        [
          "Baseline Measures of stroke symptom severity",
          "Glasgow Coma Scale (GCS) score"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of nicardipine infusion",
        "Maximum Dose of Nicardipine Used"
      ],
      "remaining_candidate_features": [
        "Location of intracerebral hemorrhage",
        "History of chronic hypertension",
        "History of ischemic stroke",
        "Serum creatinine level",
        "Platelet count",
        "Blood glucose level",
        "History of congestive heart failure",
        "History of myocardial infarction",
        "Use of anticoagulants",
        "Use of antihypertensive medications"
      ]
    },
    "processed-gen-response": "Age, Gender, Baseline systolic blood pressure, Glasgow Coma Scale (GCS) score, Hematoma volume, Location of intracerebral hemorrhage, History of chronic hypertension, History of ischemic stroke, Serum creatinine level, Platelet count, Blood glucose level, History of congestive heart failure, History of myocardial infarction, Use of anticoagulants, Use of antihypertensive medications, Time from symptom onset to treatment initiation."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Glasgow Coma Scale (GCS) score, Hematoma volume, Systolic Blood Pressure, Diastolic Blood Pressure, History of Hypertension, Time from symptom onset to treatment initiation,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Baseline Measures - Timing of Treatment",
          "Time from symptom onset to treatment initiation"
        ],
        [
          "Initial SBP",
          "Systolic Blood Pressure"
        ],
        [
          "Initial Hematoma Volume",
          "Hematoma volume"
        ],
        [
          "Baseline Measures of stroke symptom severity",
          "Glasgow Coma Scale (GCS) score"
        ]
      ],
      "remaining_reference_features": [
        "Duration of nicardipine infusion",
        "Maximum Dose of Nicardipine Used"
      ],
      "remaining_candidate_features": [
        "Diastolic Blood Pressure",
        "History of Hypertension"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Glasgow Coma Scale (GCS) score, Hematoma volume, Systolic Blood Pressure, Diastolic Blood Pressure, History of Hypertension, Time from symptom onset to treatment initiation"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Admission Systolic Blood Pressure, Admission Diastolic Blood Pressure, Glasgow Coma Scale (GCS) Score, National Institutes of Health Stroke Scale (NIHSS) Score, Hematoma Volume, History of Chronic Hypertension, History of Diabetes Mellitus.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Initial SBP",
          "Admission Systolic Blood Pressure"
        ],
        [
          "Initial Hematoma Volume",
          "Hematoma Volume"
        ],
        [
          "Baseline Measures of stroke symptom severity",
          "Glasgow Coma Scale (GCS) Score"
        ]
      ],
      "remaining_reference_features": [
        "Baseline Measures - Timing of Treatment",
        "Duration of nicardipine infusion",
        "Maximum Dose of Nicardipine Used"
      ],
      "remaining_candidate_features": [
        "Admission Diastolic Blood Pressure",
        "National Institutes of Health Stroke Scale (NIHSS) Score",
        "History of Chronic Hypertension",
        "History of Diabetes Mellitus"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Admission Systolic Blood Pressure, Admission Diastolic Blood Pressure, Glasgow Coma Scale (GCS) Score, National Institutes of Health Stroke Scale (NIHSS) Score, Hematoma Volume, History of Chronic Hypertension, History of Diabetes Mellitus."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), medical history (hypertension, diabetes, hyperlipidemia, etc.), smoking status, alcohol consumption, GCS score, NIHSS score, hematoma volume, location of ICH, systolic blood pressure, diastolic blood pressure, heart rate, blood glucose level, serum creatinine level, platelet count, history of previous stroke or transient ischemic attack, use of antihypertensive medications, use of antiplatelet or anticoagulant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Initial SBP",
          "systolic blood pressure"
        ],
        [
          "Initial Hematoma Volume",
          "hematoma volume"
        ],
        [
          "Baseline Measures of stroke symptom severity",
          "NIHSS score"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Baseline Measures - Timing of Treatment",
        "Duration of nicardipine infusion",
        "Maximum Dose of Nicardipine Used"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "weight",
        "height",
        "body mass index (BMI)",
        "medical history (hypertension, diabetes, hyperlipidemia, etc.)",
        "smoking status",
        "alcohol consumption",
        "GCS score",
        "diastolic blood pressure",
        "heart rate",
        "blood glucose level",
        "serum creatinine level",
        "platelet count",
        "history of previous stroke or transient ischemic attack",
        "use of antihypertensive medications",
        "use of antiplatelet or anticoagulant medications"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), medical history (hypertension, diabetes, hyperlipidemia, etc.), smoking status, alcohol consumption, GCS score, NIHSS score, hematoma volume, location of ICH, systolic blood pressure, diastolic blood pressure, heart rate, blood glucose level, serum creatinine level, platelet count, history of previous stroke or transient ischemic attack, use of antihypertensive medications, use of antiplatelet or anticoagulant medications."
  }
}